Kamila Mozga1, Olga Synowiecka1, Igor Rydzyk1, Anna Marek1, Ewelina Wieczorek1, Alicja Petniak2,*, Paulina Gil-Kulik2
Oncology Research, Vol.34, No.2, 2026, DOI:10.32604/or.2025.070505
- 19 January 2026
Abstract Objectives: Immunotherapy based on immune checkpoint blockade (ICB) has become a key treatment for melanoma. However, the increasing number of cases of melanoma resistant to immunotherapy highlights the need to develop methods to overcome this resistance. This study aims to collect the most recent information on melanoma immunotherapy, discuss potential strategies to overcome resistance to immunotherapy, and identify areas that require further analysis. Methods: To achieve this goal, scientific publications from 2021–2024 available in PubMed and Google Scholar databases were analyzed. The databases were searched using the following terms: “melanoma”, “immunotherapy”, “Immune Checkpoint Blockade”, and More >